Government costs could rise $2.3 billion without Obamacare payments: study
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Humana (HUM) PT Raised to $200 at Cantor Fitzgerald on Positive 1Q Pre-Announce & Investor Day; 'Increases 2017 Guidance'
April 25, 2017 3:42 PM EDTCantor Fitzgerald raised its price target on Humana (NYSE: HUM) to $200.00 (from $190.00) while maintaining a Neutral rating, following the company's first quarter earnings pre-announcement ahead of Investor Day.
Analyst Steven Halper notes the company delivered first quarter adjust EPS of $2.75, above $2.50 estimates driven... More
